Selected research
Industry Growth & Trends
Global Canine Cancer Screening Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Canine Cancer Screening market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Canine Cancer Screening is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Canine Cancer Screening is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Canine Cancer Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Canine Cancer Screening market include IDEXX, Mars Pedtcare, Zoetis, PetDx, Molecular Diagnostics (MDxHealth), Biomérieux SA, OncoK9, Antech Diagnostics and VolitionRx Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Canine Cancer Screening market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Canine Cancer Screening market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Canine Cancer Screening market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Canine Cancer Screening.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Canine Cancer Screening market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Canine Cancer Screening Market by Company
IDEXX
Mars Pedtcare
Zoetis
PetDx
Molecular Diagnostics (MDxHealth)
Biomérieux SA
OncoK9
Antech Diagnostics
VolitionRx Limited
Oncotect
Heska Corporation
Canine Cancer Screening Segment by Type
Liquid Biopsy (Blood-Based Tests)
Tissue Biopsy
Genomic Testing
Biomarker Tests
Canine Cancer Screening Segment by Application
Veterinary Clinics
Veterinary Hospitals
Other
Canine Cancer Screening Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Cancer Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Canine Cancer Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Cancer Screening.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Canine Cancer Screening companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid Biopsy (Blood-Based Tests)
- Tissue Biopsy
- Genomic Testing
- Biomarker Tests
Applications
- Veterinary Clinics
- Veterinary Hospitals
- Other
Companies covered
- IDEXX
- Mars Pedtcare
- Zoetis
- PetDx
- Molecular Diagnostics (MDxHealth)
- Biomérieux SA
- OncoK9
- Antech Diagnostics
- VolitionRx Limited
- Oncotect
- Heska Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Canine Cancer Screening Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Canine Cancer Screening Market Size by Region (2021-2032)
- 1.4.1 Global Canine Cancer Screening Market Size by Region (2021-2026)
- 1.4.2 Global Canine Cancer Screening Market Size by Region (2027-2032)
- 1.5 Key Regions Canine Cancer Screening Market Size (2021-2032)
- 1.5.1 North America Canine Cancer Screening Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Canine Cancer Screening Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Canine Cancer Screening Market Size Growth Rate (2021-2032)
- 1.5.4 South America Canine Cancer Screening Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Canine Cancer Screening Market Size Growth Rate (2021-2032)
2 Canine Cancer Screening Market by Type
- 2.1 Type Introduction
- 2.1.1 Liquid Biopsy (Blood-Based Tests)
- 2.1.2 Tissue Biopsy
- 2.1.3 Genomic Testing
- 2.1.4 Biomarker Tests
- 2.2 Global Canine Cancer Screening Market Size by Type
- 2.2.1 Global Canine Cancer Screening Market Size Overview by Type (2021-2032)
- 2.2.2 Global Canine Cancer Screening Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Canine Cancer Screening Market Size Forecasted by Type (2027-2032)
- 2.3 Global Canine Cancer Screening Market Size by Regions
- 2.3.1 North America Canine Cancer Screening Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Canine Cancer Screening Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Canine Cancer Screening Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Canine Cancer Screening Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Canine Cancer Screening Market Size Breakdown by Type (2021-2026)
3 Canine Cancer Screening Market by Application
- 3.1 Type Introduction
- 3.1.1 Veterinary Clinics
- 3.1.2 Veterinary Hospitals
- 3.1.3 Other
- 3.2 Global Canine Cancer Screening Market Size by Application
- 3.2.1 Global Canine Cancer Screening Market Size Overview by Application (2021-2032)
- 3.2.2 Global Canine Cancer Screening Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Canine Cancer Screening Market Size Forecasted by Application (2027-2032)
- 3.3 Global Canine Cancer Screening Market Size by Regions
- 3.3.1 North America Canine Cancer Screening Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Canine Cancer Screening Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Canine Cancer Screening Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Canine Cancer Screening Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Canine Cancer Screening Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Canine Cancer Screening Industry Trends
- 4.2 Canine Cancer Screening Industry Drivers
- 4.3 Canine Cancer Screening Industry Opportunities and Challenges
- 4.4 Canine Cancer Screening Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Canine Cancer Screening Revenue (2021-2026)
- 5.2 Global Canine Cancer Screening Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Canine Cancer Screening Key Company Headquarters & Area Served
- 5.4 Global Canine Cancer Screening Company, Product Type & Application
- 5.5 Global Canine Cancer Screening Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Canine Cancer Screening Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Canine Cancer Screening Players Market Share by Revenue in 2025
- 5.6.3 2025 Canine Cancer Screening Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 IDEXX
- 6.1.1 IDEXX Company Information
- 6.1.2 IDEXX Business Overview
- 6.1.3 IDEXX Canine Cancer Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 IDEXX Canine Cancer Screening Product Portfolio
- 6.1.5 IDEXX Recent Developments
- 6.2 Mars Pedtcare
- 6.2.1 Mars Pedtcare Company Information
- 6.2.2 Mars Pedtcare Business Overview
- 6.2.3 Mars Pedtcare Canine Cancer Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Mars Pedtcare Canine Cancer Screening Product Portfolio
- 6.2.5 Mars Pedtcare Recent Developments
- 6.3 Zoetis
- 6.3.1 Zoetis Company Information
- 6.3.2 Zoetis Business Overview
- 6.3.3 Zoetis Canine Cancer Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Zoetis Canine Cancer Screening Product Portfolio
- 6.3.5 Zoetis Recent Developments
- 6.4 PetDx
- 6.4.1 PetDx Company Information
- 6.4.2 PetDx Business Overview
- 6.4.3 PetDx Canine Cancer Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 PetDx Canine Cancer Screening Product Portfolio
- 6.4.5 PetDx Recent Developments
- 6.5 Molecular Diagnostics (MDxHealth)
- 6.5.1 Molecular Diagnostics (MDxHealth) Company Information
- 6.5.2 Molecular Diagnostics (MDxHealth) Business Overview
- 6.5.3 Molecular Diagnostics (MDxHealth) Canine Cancer Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Molecular Diagnostics (MDxHealth) Canine Cancer Screening Product Portfolio
- 6.5.5 Molecular Diagnostics (MDxHealth) Recent Developments
- 6.6 Biomérieux SA
- 6.6.1 Biomérieux SA Company Information
- 6.6.2 Biomérieux SA Business Overview
- 6.6.3 Biomérieux SA Canine Cancer Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Biomérieux SA Canine Cancer Screening Product Portfolio
- 6.6.5 Biomérieux SA Recent Developments
- 6.7 OncoK9
- 6.7.1 OncoK9 Company Information
- 6.7.2 OncoK9 Business Overview
- 6.7.3 OncoK9 Canine Cancer Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 OncoK9 Canine Cancer Screening Product Portfolio
- 6.7.5 OncoK9 Recent Developments
- 6.8 Antech Diagnostics
- 6.8.1 Antech Diagnostics Company Information
- 6.8.2 Antech Diagnostics Business Overview
- 6.8.3 Antech Diagnostics Canine Cancer Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Antech Diagnostics Canine Cancer Screening Product Portfolio
- 6.8.5 Antech Diagnostics Recent Developments
- 6.9 VolitionRx Limited
- 6.9.1 VolitionRx Limited Company Information
- 6.9.2 VolitionRx Limited Business Overview
- 6.9.3 VolitionRx Limited Canine Cancer Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 VolitionRx Limited Canine Cancer Screening Product Portfolio
- 6.9.5 VolitionRx Limited Recent Developments
- 6.10 Oncotect
- 6.10.1 Oncotect Company Information
- 6.10.2 Oncotect Business Overview
- 6.10.3 Oncotect Canine Cancer Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Oncotect Canine Cancer Screening Product Portfolio
- 6.10.5 Oncotect Recent Developments
- 6.11 Heska Corporation
- 6.11.1 Heska Corporation Company Information
- 6.11.2 Heska Corporation Business Overview
- 6.11.3 Heska Corporation Canine Cancer Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Heska Corporation Canine Cancer Screening Product Portfolio
- 6.11.5 Heska Corporation Recent Developments
7 North America
- 7.1 North America Canine Cancer Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Canine Cancer Screening Market Size by Country (2021-2026)
- 7.3 North America Canine Cancer Screening Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Canine Cancer Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Canine Cancer Screening Market Size by Country (2021-2026)
- 8.3 Europe Canine Cancer Screening Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Canine Cancer Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Canine Cancer Screening Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Canine Cancer Screening Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Canine Cancer Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Canine Cancer Screening Market Size by Country (2021-2026)
- 10.3 South America Canine Cancer Screening Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Canine Cancer Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Canine Cancer Screening Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Canine Cancer Screening Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst